GGrantIndex
Sort

10,829 grants matching car t

MYOCARDITIS--RECEPTORS FOR A CARDIOTROPIC VIRUS

$209,498
Children'S Hospital Of Philadelphia · R01 · FY2001 · HL

Chimeric antigen receptor (CAR) Tregs for treatment of ocular inflammatory diseases

$209,375
Darren James Lee · Univ Of Massachusetts Med Sch Worcester · R21 · FY2024 · EY

T cell-mediated Gene Replacement Therapy

$209,362
Brian D Brown · Icahn School Of Medicine At Mount Sinai · R21 · FY2019 · HD

Innovative Droplet Lenses for NextGen Light Sensors of Biomarkers of Inflammation

$209,197
Timothy M Swager · Massachusetts Institute Of Technology · R21 · FY2022 · CA

FitFab 4 Survivors

$209,096
Bernard F. Fuemmeler · Duke University · R21 · FY2011 · CA

Junction Adhesion Molecule CAR and the Immune System

$209,074
Steven D Carson · University Of Nebraska Medical Center · R01 · FY2007 · AI

Immune Monitoring Core

$209,007
Martin Felices · University Of Minnesota · P01 · FY2023 · CA

Characterization of cholecystokinin producing enteroendocrine cells

$208,995
Stephen Wank · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK

Core B - Tissue acquisition, Processing and Pathology (TAPP) Core

$208,657
Joseph Anthony Fraietta · University Of Pennsylvania · P01 · FY2022 · CA

Center for Cell-based Therapy - Cures

$208,597
Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

New Problems in Mean Field Control Theory

$208,559
Alain Bensoussan · University Of Texas At Dallas · · FY2016 · MPS

Enhancing Early-Phase Care for Primary Care Patients with Unhealthy Substance Use

$208,501
Dominic Hodgkin · Brandeis University · R21 · FY2013 · DA

Engineering CARs against cancer-specific glycoproteins

$208,452
David M Kranz · University Of Illinois At Urbana-Champaign · R21 · FY2020 · CA

MSKCC BMT CTN Renewal

$208,408
Miguel-Angel Perales · Sloan-Kettering Inst Can Research · UG1 · FY2019 · HL

TEXT4DIET

$208,357
Sheri Thompson · Santech, Inc. · R44 · FY2009 · CA

Delineating mechanisms underlying the enhanced stability and functionality of CD2- KO Tregs and chimeric antigen receptor (CAR) Tregs and their application in xenotransplantation

$208,125
Mohsen Khosravi Maharlooei · Mayo Clinic Arizona · R21 · FY2024 · AI

Tasquinimod as an adjunct to immunotherapies administered peri-operatively

$208,097
Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2021 · CA

Monitoring Outside the Home of Older Adults at Risk for Sudden Cardiac Death

$208,037
Timothy H. Riehle · Koronis Biomedical Technologies Corporat · R43 · FY2012 · AG

Development and implementation of pediatric mobile phone reflectance pulse oximeters and a hypoxemia surveillance system in South Africa

$208,030
Eric Douglass McCollum · Johns Hopkins University · R21 · FY2021 · TW

EAGER: Integration and analysis of high-dimensional dataset

$207,999
Lanjing Zhang · Rutgers University Newark · · FY2021 · CSE

Improving safety and access to immune effector cell therapy with artificial intelligence technology

$207,895
Veronika S Bachanova · University Of Minnesota · R21 · FY2025 · CA

Dissecting intrinsic variability in engineered T Cell immunotherapies

$207,857
Theodore Lee Roth · Stanford University · K08 · FY2025 · CA

Mobile-based Care for children with Autism Spectrum Disorder using Remote Experience Sampling Method (mCARE)

$207,627
Sheikh Iqbal Ahamed · Marquette University · R21 · FY2018 · MH

PeerNaija: A Mobile Health Platform Incentivizing Medication Adherence Among Youth Living with HIV in Nigeria

$207,591
Aimalohi Ahonkhai · Vanderbilt University Medical Center · R21 · FY2019 · TW

Bifunctional Chimeric Antigen Receptors for clearing HIV

$207,457
Jason T Kimata · Baylor College Of Medicine · R21 · FY2017 · AI